RBGPF Stock Recent News

Indivior PLC (LSE:INDV, NASDAQ:INDV) has won a case in the High Court against it and former parent Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) after being hit by a lawsuit over the Suboxone branded opioid addiction drug.  In September, Wirral Council filed a claim that Indivior had made misleading or dishonest statements regarding an alleged fraudulent scheme to the market for its Suboxone products in published information relating, violating the Financial Services and Markets Act 2000.

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) chairman Chris Sinclair will step down next year and be replaced by former Sky chief executive Jeremy Darroch, making a 12-month clean sweep at the top of the Vanish and Cilit Bang maker.  Sinclair will have served a nine-year term on the board, including six as chair, by the time of the annual shareholder meeting next May, when he will hand over the role.

Reckitt Benckiser has struggled to consistently exploit its portfolio of premium brands and return to its historical growth trajectory. The company's third-quarter performance was impacted by foreign exchange headwinds, but this does not necessarily indicate underlying weakness. The lack of consistency in Reckitt's earnings growth strategy has affected its fair valuation, although it has the potential for strong business performance.

Reckitt Benckiser reported mediocre third quarter results and provided a strategy update recently. While that strategy update was mostly a reaffirmation that Reckitt Benckiser is positioned well in a growing market, it announced a new share buyback program. While the company is continuing to struggle, I still see the business having a wide economic moat as well as the stock being undervalued.

Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) has named Shannon Eisenhardt as its new chief financial officer, in another change in the top team at the consumer goods maker. The manufacturer of Nurofen and Dettol said Eisenhardt will join the business on October 17, succeeding Jeff Carr who has announced his retirement.

Reckitt Benckiser is “cheap” compared to the sector and against its own history, according to Deutsch Bank, although it is “tough to re-rate.” However, the broker believes it is “only moderately cheap against the market.

Reckitt Benckiser Group plc (OTCPK:RBGPF) Q2 2023 Earnings Call Transcript July 26, 2023 8:30 AM ET Company Participants Richard Joyce - IR Nicandro Durante - CEO Jeff Carr - CFO Kris Licht - CEO Designate Conference Call Participants Tom Sykes - Deutsche Bank Jeremy Fialko - HSBC Fulvio Cazzol - Berenberg Iain Simpson - Barclays Richard Cohen - Morgan Stanley Alicia Forry - Investec Karel Zoete - Kepler Cheuvreux Operator Good morning, everyone. Welcome to Reckitt's Half Year 2023 Results Presentation.

Durex and Veet owner Reckitt Benckiser said first-half revenues moved higher with the consumer goods reiterating its confidence amid a challenging backdrop. Revenue grew to £7.4bn in the first six months of the year, an 8.1% increase compared to the same period 12 months ago and 6% growth like-for-like.

Reckitt Benckiser Group is a global manufacturer and seller of health, hygiene, and nutrition products. Reckitt has benefited well from the pandemic, but is fundamentally attractive due to the brands it owns. Margins are above the industry average, allowing Reckitt to deleverage and fund distributions.

Reckitt Benckiser Group plc (OTCPK:RBGLY) Q1 2023 Results Conference Call April 26, 2023 1:00 PM ET Company Participants Richard Joyce - IR Nicandro Durante - CEO Jeff Carr - CFO Conference Call Participants Rashad Kawan - Morgan Stanley Guillaume Delmas - UBS Celine Pannuti - JPMorgan Bruno Monteyne - Bernstein James Edwardes Jones - RBC Iain Simpson - Barclays Jeremy Fialko - HSBC Martin Deboo - Jefferies Tom Sykes - Deutsche Bank Chris Pitcher - Redburn Karel Zoete - Kepler Richard Joyce Good morning, everyone. Welcome to Reckitt's Q1 trading update.